| MicroRNAs: processing, maturation, target recognition and regulatory functions GC Shukla, J Singh, S Barik Molecular and cellular pharmacology 3 (3), 83, 2011 | 1028 | 2011 |
| Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression Y Zhang, S Pitchiaya, M Cieślik, YS Niknafs, JCY Tien, Y Hosono, MK Iyer, ... Nature genetics 50 (6), 814-824, 2018 | 201 | 2018 |
| MicroRNAs in prostate cancer: Functional role as biomarkers R Kanwal, AR Plaga, X Liu, GC Shukla, S Gupta Cancer Letters 407, 9-20, 2017 | 148 | 2017 |
| miR 488* inhibits androgen receptor expression in prostate carcinoma cells K Sikand, JE Slaibi, R Singh, SD Slane, GC Shukla International Journal of Cancer 129 (4), 810-819, 2011 | 140 | 2011 |
| A boost for the emerging field of RNA nanotechnology: report on the first international conference on RNA nanotechnology GC Shukla, F Haque, Y Tor, LM Wilhelmsson, JJ Toulme, H Isambert, ... ACS nano 5 (5), 3405-3418, 2011 | 127 | 2011 |
| Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin are targets of miR-644a K Sikand, J Singh, JS Ebron, GC Shukla Public Library of Science 7 (10), e47510, 2012 | 111 | 2012 |
| Soil enzymology G Shukla, A Varma Springer Science & Business Media, 2010 | 105 | 2010 |
| A catalytically active group II intron domain 5 can function in the U12-dependent spliceosome GC Shukla, RA Padgett Molecular cell 9 (5), 1145-1150, 2002 | 95 | 2002 |
| Androgen receptor‐related diseases: what do we know? GC Shukla, AR Plaga, E Shankar, S Gupta Andrology 4 (3), 366-381, 2016 | 70 | 2016 |
| Conservation of functional features of U6atac and U12 snRNAs between vertebrates and higher plants GC SHUKLA, RA PADGETT Rna 5 (4), 525-538, 1999 | 70 | 1999 |
| A comprehensive review of web-based non-coding RNA resources for cancer research Y Zheng, L Liu, GC Shukla Cancer letters 407, 1-8, 2017 | 67 | 2017 |
| Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells K Sikand, SD Slane, GC Shukla Cancer cell international 9, 1-13, 2009 | 52 | 2009 |
| miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies S Al-Harbi, GS Choudhary, JS Ebron, BT Hill, N Vivekanathan, AH Ting, ... Molecular cancer 14, 1-17, 2015 | 50 | 2015 |
| MiR-644a disrupts oncogenic transformation and warburg effect by direct modulation of multiple genes of tumor-promoting pathways JS Ebron, E Shankar, J Singh, K Sikand, CM Weyman, S Gupta, ... Cancer Research 79 (8), 1844-1856, 2019 | 40 | 2019 |
| Aging and calorie restriction regulate the expression of miR-125a-5p and its target genes Stat3, Casp2 and Stard13 K Makwana, SA Patel, N Velingkaar, JS Ebron, GC Shukla, RV Kondratov Aging (Albany NY) 9 (7), 1825, 2017 | 37 | 2017 |
| Domains of human U4atac snRNA required for U12‐dependent splicing in vivo GC Shukla, AJ Cole, RC Dietrich, RA Padgett Nucleic acids research 30 (21), 4650-4657, 2002 | 36 | 2002 |
| The intramolecular stem-loop structure of U6 snRNA can functionally replace the U6atac snRNA stem-loop. GC Shukla, RA Padgett RNA 7 (1), 94-105, 2001 | 34 | 2001 |
| Regulation of cholesterol biosynthesis and lipid metabolism: A microRNA management perspective A Bhattarai, EM Likos, CM Weyman, GC Shukla Steroids 173, 108878, 2021 | 33 | 2021 |
| A revised model for U4atac/U6atac snRNA base pairing RA Padgett, GC Shukla RNA 8 (2), 125-128, 2002 | 26 | 2002 |
| Alternative splicing of U12-dependent introns in vivo responds to purine-rich enhancers RC DIETRICH, GC SHUKLA, JD FULLER, RA PADGETT RNA 7 (10), 1378-1388, 2001 | 26 | 2001 |
